Insys Therapeutics

About Insys Therapeutics

Insys Therapeutics filed for bankruptcy on June 24, 2019, shortly after founder John Kapoor was convicted of racketeering for bribing doctors to prescribe Subsys, a fentanyl spray. Kapoor was sentenced to 5 and a half years. Other executives received prison sentences. Insys had marketed Subsys to non cancer patients despite the drug being approved only for cancer pain. The company used provocative marketing materials, including a music video showing employees dancing as a bottle of fentanyl rained money. The case was one of the few where pharmaceutical executives faced criminal charges. Insys settled with the DOJ for 225 million. The company liquidated in bankruptcy, with its assets sold to reduce liabilities.